

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.10070347 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.88206144 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.88206144 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.87439534 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 5.64721807 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 5.64721807 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.64721807 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.64721807 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.64721807 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 5.64721807 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.16256004 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.07092846 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.04897900 |
| 14 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.70867040 |
| 15 | detection of other organism (GO:0098543) | 4.61111595 |
| 16 | neutrophil activation involved in immune response (GO:0002283) | 4.60766543 |
| 17 | macrophage activation involved in immune response (GO:0002281) | 4.60523806 |
| 18 | detection of molecule of bacterial origin (GO:0032490) | 4.49472804 |
| 19 | L-phenylalanine catabolic process (GO:0006559) | 4.45328015 |
| 20 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.45328015 |
| 21 | alpha-linolenic acid metabolic process (GO:0036109) | 4.43122004 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.41189835 |
| 23 | L-phenylalanine metabolic process (GO:0006558) | 4.41189835 |
| 24 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.37395681 |
| 25 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.35755921 |
| 26 | lysine metabolic process (GO:0006553) | 4.35280614 |
| 27 | lysine catabolic process (GO:0006554) | 4.35280614 |
| 28 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.34191742 |
| 29 | regulation of gamma-delta T cell activation (GO:0046643) | 4.31141159 |
| 30 | response to peptidoglycan (GO:0032494) | 4.30396635 |
| 31 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.26197817 |
| 32 | cellular extravasation (GO:0045123) | 4.23577087 |
| 33 | detection of bacterium (GO:0016045) | 4.23370232 |
| 34 | kynurenine metabolic process (GO:0070189) | 4.16101447 |
| 35 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.15789118 |
| 36 | detection of external biotic stimulus (GO:0098581) | 4.15513305 |
| 37 | complement activation, alternative pathway (GO:0006957) | 4.09767309 |
| 38 | aromatic amino acid family catabolic process (GO:0009074) | 4.06049495 |
| 39 | protein carboxylation (GO:0018214) | 4.04603134 |
| 40 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.04603134 |
| 41 | leukocyte aggregation (GO:0070486) | 4.03973249 |
| 42 | negative regulation of interleukin-12 production (GO:0032695) | 4.02314640 |
| 43 | glyoxylate metabolic process (GO:0046487) | 3.93655953 |
| 44 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.93556474 |
| 45 | response to host immune response (GO:0052572) | 3.93556474 |
| 46 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.92263642 |
| 47 | sulfur amino acid catabolic process (GO:0000098) | 3.91426152 |
| 48 | negative regulation of fibrinolysis (GO:0051918) | 3.88366682 |
| 49 | urea metabolic process (GO:0019627) | 3.86511610 |
| 50 | urea cycle (GO:0000050) | 3.86511610 |
| 51 | response to interleukin-15 (GO:0070672) | 3.85632584 |
| 52 | immunoglobulin mediated immune response (GO:0016064) | 3.83829695 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 3.83462647 |
| 54 | cysteine metabolic process (GO:0006534) | 3.80716949 |
| 55 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.79048302 |
| 56 | regulation of protein activation cascade (GO:2000257) | 3.76999350 |
| 57 | 2-oxoglutarate metabolic process (GO:0006103) | 3.74614561 |
| 58 | response to host (GO:0075136) | 3.73668264 |
| 59 | response to host defenses (GO:0052200) | 3.73668264 |
| 60 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.73668264 |
| 61 | indole-containing compound catabolic process (GO:0042436) | 3.72951666 |
| 62 | indolalkylamine catabolic process (GO:0046218) | 3.72951666 |
| 63 | tryptophan catabolic process (GO:0006569) | 3.72951666 |
| 64 | bile acid biosynthetic process (GO:0006699) | 3.69199183 |
| 65 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.67298304 |
| 66 | fatty acid transmembrane transport (GO:1902001) | 3.67294446 |
| 67 | microglial cell activation (GO:0001774) | 3.64278084 |
| 68 | neutrophil activation (GO:0042119) | 3.63704637 |
| 69 | B cell receptor signaling pathway (GO:0050853) | 3.63058853 |
| 70 | positive thymic T cell selection (GO:0045059) | 3.62478177 |
| 71 | regulation of complement activation (GO:0030449) | 3.61823779 |
| 72 | amino-acid betaine metabolic process (GO:0006577) | 3.61210384 |
| 73 | phospholipid homeostasis (GO:0055091) | 3.59773503 |
| 74 | detection of biotic stimulus (GO:0009595) | 3.58572817 |
| 75 | ethanol oxidation (GO:0006069) | 3.57057959 |
| 76 | tryptophan metabolic process (GO:0006568) | 3.55464814 |
| 77 | cellular response to interleukin-15 (GO:0071350) | 3.53902143 |
| 78 | high-density lipoprotein particle remodeling (GO:0034375) | 3.51993766 |
| 79 | nitrogen cycle metabolic process (GO:0071941) | 3.50889447 |
| 80 | negative thymic T cell selection (GO:0045060) | 3.49729084 |
| 81 | plasma lipoprotein particle clearance (GO:0034381) | 3.48655597 |
| 82 | negative T cell selection (GO:0043383) | 3.48391220 |
| 83 | regulation of fibrinolysis (GO:0051917) | 3.46947101 |
| 84 | homocysteine metabolic process (GO:0050667) | 3.46397988 |
| 85 | fatty acid beta-oxidation (GO:0006635) | 3.45624087 |
| 86 | respiratory burst (GO:0045730) | 3.44287440 |
| 87 | regulation of cholesterol homeostasis (GO:2000188) | 3.43315461 |
| 88 | myeloid cell activation involved in immune response (GO:0002275) | 3.38921398 |
| 89 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.38679503 |
| 90 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.37810116 |
| 91 | macrophage activation (GO:0042116) | 3.37571315 |
| 92 | negative regulation of T cell mediated immunity (GO:0002710) | 3.37407326 |
| 93 | cellular ketone body metabolic process (GO:0046950) | 3.33312262 |
| 94 | serine family amino acid catabolic process (GO:0009071) | 3.32928695 |
| 95 | regulation of T cell tolerance induction (GO:0002664) | 3.31981981 |
| 96 | granulocyte activation (GO:0036230) | 3.31573650 |
| 97 | valine metabolic process (GO:0006573) | 3.31459161 |
| 98 | type I interferon signaling pathway (GO:0060337) | 3.31391765 |
| 99 | cellular response to type I interferon (GO:0071357) | 3.31391765 |
| 100 | carnitine shuttle (GO:0006853) | 3.30416408 |
| 101 | positive regulation of interferon-alpha production (GO:0032727) | 3.30314933 |
| 102 | fatty acid oxidation (GO:0019395) | 3.29715143 |
| 103 | response to type I interferon (GO:0034340) | 3.29345453 |
| 104 | phospholipid efflux (GO:0033700) | 3.27857869 |
| 105 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.27117729 |
| 106 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.25304799 |
| 107 | positive regulation of lipid catabolic process (GO:0050996) | 3.24491151 |
| 108 | lipid oxidation (GO:0034440) | 3.23464804 |
| 109 | reverse cholesterol transport (GO:0043691) | 3.22970290 |
| 110 | positive T cell selection (GO:0043368) | 3.22609683 |
| 111 | regulation of B cell differentiation (GO:0045577) | 3.22204266 |
| 112 | positive regulation of B cell differentiation (GO:0045579) | 3.21152458 |
| 113 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.20104997 |
| 114 | bile acid metabolic process (GO:0008206) | 3.19291733 |
| 115 | neutrophil mediated immunity (GO:0002446) | 3.19229187 |
| 116 | triglyceride homeostasis (GO:0070328) | 3.19073850 |
| 117 | acylglycerol homeostasis (GO:0055090) | 3.19073850 |
| 118 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.18993467 |
| 119 | low-density lipoprotein particle clearance (GO:0034383) | 3.18913889 |
| 120 | acetyl-CoA metabolic process (GO:0006084) | 3.18671963 |
| 121 | negative regulation of sterol transport (GO:0032372) | 3.18647690 |
| 122 | negative regulation of cholesterol transport (GO:0032375) | 3.18647690 |
| 123 | B cell mediated immunity (GO:0019724) | 3.17936714 |
| 124 | regulation of tolerance induction (GO:0002643) | 3.17020630 |
| 125 | T cell selection (GO:0045058) | 3.15923305 |
| 126 | T cell migration (GO:0072678) | 3.13571671 |
| 127 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.11421444 |
| 128 | fatty acid catabolic process (GO:0009062) | 3.10392575 |
| 129 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.08676153 |
| 130 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.08038087 |
| 131 | regulation of interferon-alpha production (GO:0032647) | 3.07730220 |
| 132 | regulation of sequestering of triglyceride (GO:0010889) | 3.06154449 |
| 133 | regulation of mast cell degranulation (GO:0043304) | 3.05950347 |
| 134 | protein-lipid complex remodeling (GO:0034368) | 3.05885265 |
| 135 | macromolecular complex remodeling (GO:0034367) | 3.05885265 |
| 136 | plasma lipoprotein particle remodeling (GO:0034369) | 3.05885265 |
| 137 | thymic T cell selection (GO:0045061) | 3.04688869 |
| 138 | aspartate family amino acid catabolic process (GO:0009068) | 3.04540689 |
| 139 | response to muramyl dipeptide (GO:0032495) | 3.03991040 |
| 140 | short-chain fatty acid metabolic process (GO:0046459) | 3.02643906 |
| 141 | carnitine metabolic process (GO:0009437) | 3.01550561 |
| 142 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.01257509 |
| 143 | regulation of cholesterol storage (GO:0010885) | 2.99442649 |
| 144 | alpha-amino acid catabolic process (GO:1901606) | 2.98896735 |
| 145 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.98504075 |
| 146 | defense response to protozoan (GO:0042832) | 2.97654455 |
| 147 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.97507624 |
| 148 | myeloid leukocyte mediated immunity (GO:0002444) | 2.96978376 |
| 149 | dendritic cell migration (GO:0036336) | 2.95762004 |
| 150 | monocarboxylic acid catabolic process (GO:0072329) | 2.95562312 |
| 151 | regulation of cholesterol esterification (GO:0010872) | 2.95348413 |
| 152 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.94336142 |
| 153 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94289884 |
| 154 | growth hormone receptor signaling pathway (GO:0060396) | 2.93657953 |
| 155 | bile acid and bile salt transport (GO:0015721) | 2.93401668 |
| 156 | ethanol metabolic process (GO:0006067) | 2.93193438 |
| 157 | positive regulation of fatty acid oxidation (GO:0046321) | 2.92164385 |
| 158 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.91084390 |
| 159 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.91084390 |
| 160 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.89592406 |
| 161 | cholesterol homeostasis (GO:0042632) | 2.88644472 |
| 162 | dendritic cell chemotaxis (GO:0002407) | 2.88587279 |
| 163 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.87611557 |
| 164 | cholesterol efflux (GO:0033344) | 2.87610089 |
| 165 | sterol homeostasis (GO:0055092) | 2.87375101 |
| 166 | plasma lipoprotein particle assembly (GO:0034377) | 2.87214705 |
| 167 | positive regulation of mast cell activation (GO:0033005) | 2.86660529 |
| 168 | ketone body metabolic process (GO:1902224) | 2.85605472 |
| 169 | cellular modified amino acid catabolic process (GO:0042219) | 2.85303295 |
| 170 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.85262115 |
| 171 | germinal center formation (GO:0002467) | 2.85060238 |
| 172 | aromatic amino acid family metabolic process (GO:0009072) | 2.84146889 |
| 173 | regulation of fatty acid oxidation (GO:0046320) | 2.84060629 |
| 174 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.83346922 |
| 175 | regulation of regulatory T cell differentiation (GO:0045589) | 2.82718905 |
| 176 | surfactant homeostasis (GO:0043129) | 2.82681938 |
| 177 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.82388826 |
| 178 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.82388826 |
| 179 | tolerance induction (GO:0002507) | 2.82048865 |
| 180 | cellular glucuronidation (GO:0052695) | 2.81794907 |
| 181 | leukocyte degranulation (GO:0043299) | 2.80497581 |
| 182 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.80450568 |
| 183 | fibrinolysis (GO:0042730) | 2.80406908 |
| 184 | tyrosine metabolic process (GO:0006570) | 2.79814871 |
| 185 | cellular amino acid catabolic process (GO:0009063) | 2.79272105 |
| 186 | positive regulation of tolerance induction (GO:0002645) | 2.79180445 |
| 187 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.78608192 |
| 188 | 4-hydroxyproline metabolic process (GO:0019471) | 2.76897132 |
| 189 | regulation of leukocyte degranulation (GO:0043300) | 2.76565506 |
| 190 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.76323109 |
| 191 | protein-lipid complex assembly (GO:0065005) | 2.76224967 |
| 192 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.75925077 |
| 193 | glutamate metabolic process (GO:0006536) | 2.75854668 |
| 194 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 2.74230483 |
| 195 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.73174745 |
| 196 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.72217357 |
| 197 | tricarboxylic acid metabolic process (GO:0072350) | 2.71236494 |
| 198 | positive regulation of lipid storage (GO:0010884) | 2.70271085 |
| 199 | regulation of triglyceride metabolic process (GO:0090207) | 2.70137861 |
| 200 | lipoprotein metabolic process (GO:0042157) | 2.69575264 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.22347400 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.21507797 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.83790779 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.76663001 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.39426631 |
| 6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.24246870 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.15555495 |
| 8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.95473452 |
| 9 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.90700014 |
| 10 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.80156641 |
| 11 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.77384169 |
| 12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.56726934 |
| 13 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.54345281 |
| 14 | MYB_26560356_Chip-Seq_TH2_Human | 2.53733029 |
| 15 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.53078670 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.42136365 |
| 17 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.41780099 |
| 18 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.41173724 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.37232832 |
| 20 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.36178842 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.28642526 |
| 22 | MYB_26560356_Chip-Seq_TH1_Human | 2.26949921 |
| 23 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.24285769 |
| 24 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.13171884 |
| 25 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.12259157 |
| 26 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.07230428 |
| 27 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.00963971 |
| 28 | GATA1_22025678_ChIP-Seq_K562_Human | 2.00086926 |
| 29 | UTX_26944678_Chip-Seq_JUKART_Human | 1.99554615 |
| 30 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.92277633 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.84815772 |
| 32 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.82151309 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.72571569 |
| 34 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.72116997 |
| 35 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.69300115 |
| 36 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.67029522 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66495425 |
| 38 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.65369620 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.63141794 |
| 40 | MAF_26560356_Chip-Seq_TH2_Human | 1.62911539 |
| 41 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.62544423 |
| 42 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.62056373 |
| 43 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.58855101 |
| 44 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.56955700 |
| 45 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.55136240 |
| 46 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.54835717 |
| 47 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.53897472 |
| 48 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.53225561 |
| 49 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.53225561 |
| 50 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.53185931 |
| 51 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.52747148 |
| 52 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.50886520 |
| 53 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.49041198 |
| 54 | * ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.48708288 |
| 55 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.48160440 |
| 56 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.47677370 |
| 57 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.47101401 |
| 58 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.47065492 |
| 59 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.46046232 |
| 60 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.44096945 |
| 61 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.43844434 |
| 62 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.42724398 |
| 63 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.42679162 |
| 64 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.39764264 |
| 65 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.39737367 |
| 66 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.39717070 |
| 67 | * GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.39227781 |
| 68 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.38196399 |
| 69 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.36871076 |
| 70 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.36592123 |
| 71 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32855050 |
| 72 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.32720730 |
| 73 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.30328267 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.30177197 |
| 75 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.27593532 |
| 76 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.26382632 |
| 77 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.26046097 |
| 78 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24572698 |
| 79 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.22456003 |
| 80 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.22452246 |
| 81 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.21557651 |
| 82 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.21176678 |
| 83 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.21170772 |
| 84 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.19804222 |
| 85 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.19746430 |
| 86 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.19358213 |
| 87 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.15913088 |
| 88 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14737995 |
| 89 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.14665483 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13455938 |
| 91 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13329908 |
| 92 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.11898031 |
| 93 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10664454 |
| 94 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.10061138 |
| 95 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.09525516 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.08754335 |
| 97 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07797575 |
| 98 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.06677580 |
| 99 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.06188457 |
| 100 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.05801648 |
| 101 | GATA1_19941826_ChIP-Seq_K562_Human | 1.04418583 |
| 102 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.04391069 |
| 103 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.04321764 |
| 104 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.04024063 |
| 105 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.03824582 |
| 106 | MAF_26560356_Chip-Seq_TH1_Human | 1.02843561 |
| 107 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02603312 |
| 108 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.02178328 |
| 109 | GATA2_19941826_ChIP-Seq_K562_Human | 1.02037415 |
| 110 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01178977 |
| 111 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00383754 |
| 112 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99794108 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.99276365 |
| 114 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.98859624 |
| 115 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.98603311 |
| 116 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.97194995 |
| 117 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96907723 |
| 118 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.96805867 |
| 119 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96145997 |
| 120 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.95888907 |
| 121 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 0.95361413 |
| 122 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.94868392 |
| 123 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.92681427 |
| 124 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92666334 |
| 125 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.92255205 |
| 126 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.92222633 |
| 127 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.91852132 |
| 128 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91698388 |
| 129 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.91102381 |
| 130 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91095430 |
| 131 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.90598600 |
| 132 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.90470504 |
| 133 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.89630212 |
| 134 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89448349 |
| 135 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.88958585 |
| 136 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.88255894 |
| 137 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.87471416 |
| 138 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.87088484 |
| 139 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86386385 |
| 140 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.86367549 |
| 141 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.85237692 |
| 142 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.84167842 |
| 143 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.83854766 |
| 144 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.83824373 |
| 145 | SPI1_23127762_ChIP-Seq_K562_Human | 0.82259560 |
| 146 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.82117906 |
| 147 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.81877912 |
| 148 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.81487716 |
| 149 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.81487716 |
| 150 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.81327634 |
| 151 | MYC_22102868_ChIP-Seq_BL_Human | 0.80341865 |
| 152 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.79461632 |
| 153 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.78535621 |
| 154 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.78397283 |
| 155 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.78313803 |
| 156 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.77657755 |
| 157 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77093260 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 5.21035010 |
| 2 | MP0005360_urolithiasis | 4.66997375 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 4.06411056 |
| 4 | MP0005365_abnormal_bile_salt | 3.79744496 |
| 5 | MP0002138_abnormal_hepatobiliary_system | 3.10232376 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.02218781 |
| 7 | MP0005671_abnormal_response_to | 2.90573897 |
| 8 | MP0001800_abnormal_humoral_immune | 2.80202255 |
| 9 | MP0003252_abnormal_bile_duct | 2.74387280 |
| 10 | MP0009840_abnormal_foam_cell | 2.74322278 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.62351874 |
| 12 | MP0002837_dystrophic_cardiac_calcinosis | 2.62168188 |
| 13 | MP0003763_abnormal_thymus_physiology | 2.50948601 |
| 14 | MP0010329_abnormal_lipoprotein_level | 2.47725938 |
| 15 | MP0003191_abnormal_cellular_cholesterol | 2.41188427 |
| 16 | MP0002723_abnormal_immune_serum | 2.40989532 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.40713039 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.36592833 |
| 19 | MP0001819_abnormal_immune_cell | 2.34320241 |
| 20 | MP0003705_abnormal_hypodermis_morpholog | 2.33387745 |
| 21 | MP0003806_abnormal_nucleotide_metabolis | 2.30723694 |
| 22 | MP0005083_abnormal_biliary_tract | 2.28377727 |
| 23 | MP0002148_abnormal_hypersensitivity_rea | 2.10308377 |
| 24 | MP0006082_CNS_inflammation | 2.06772899 |
| 25 | MP0004381_abnormal_hair_follicle | 2.04523722 |
| 26 | MP0008260_abnormal_autophagy | 1.97040199 |
| 27 | MP0001666_abnormal_nutrient_absorption | 1.92991974 |
| 28 | MP0002398_abnormal_bone_marrow | 1.92682842 |
| 29 | MP0002405_respiratory_system_inflammati | 1.83254824 |
| 30 | MP0000716_abnormal_immune_system | 1.82166848 |
| 31 | MP0010368_abnormal_lymphatic_system | 1.80986005 |
| 32 | MP0004084_abnormal_cardiac_muscle | 1.79435684 |
| 33 | MP0003300_gastrointestinal_ulcer | 1.78637761 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.76344432 |
| 35 | MP0004130_abnormal_muscle_cell | 1.75041196 |
| 36 | MP0000609_abnormal_liver_physiology | 1.74854412 |
| 37 | MP0005332_abnormal_amino_acid | 1.73855988 |
| 38 | MP0002254_reproductive_system_inflammat | 1.70928009 |
| 39 | MP0009333_abnormal_splenocyte_physiolog | 1.62748672 |
| 40 | MP0002006_tumorigenesis | 1.60539448 |
| 41 | MP0003303_peritoneal_inflammation | 1.58192240 |
| 42 | MP0002118_abnormal_lipid_homeostasis | 1.58169116 |
| 43 | MP0002396_abnormal_hematopoietic_system | 1.57456260 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.56487067 |
| 45 | MP0010234_abnormal_vibrissa_follicle | 1.55344316 |
| 46 | MP0000465_gastrointestinal_hemorrhage | 1.54550426 |
| 47 | MP0002009_preneoplasia | 1.54459229 |
| 48 | MP0002722_abnormal_immune_system | 1.53101391 |
| 49 | MP0004510_myositis | 1.51767378 |
| 50 | MP0000703_abnormal_thymus_morphology | 1.50837638 |
| 51 | MP0005310_abnormal_salivary_gland | 1.50755494 |
| 52 | MP0002132_abnormal_respiratory_system | 1.50333314 |
| 53 | MP0005319_abnormal_enzyme/_coenzyme | 1.48936207 |
| 54 | MP0000858_altered_metastatic_potential | 1.47652414 |
| 55 | MP0002429_abnormal_blood_cell | 1.45562533 |
| 56 | MP0003866_abnormal_defecation | 1.42483240 |
| 57 | MP0003172_abnormal_lysosome_physiology | 1.41511986 |
| 58 | MP0004883_abnormal_blood_vessel | 1.40396269 |
| 59 | MP0005167_abnormal_blood-brain_barrier | 1.40380184 |
| 60 | MP0003566_abnormal_cell_adhesion | 1.36289822 |
| 61 | MP0003436_decreased_susceptibility_to | 1.36039309 |
| 62 | MP0003195_calcinosis | 1.33584670 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.32285588 |
| 64 | MP0005075_abnormal_melanosome_morpholog | 1.31626809 |
| 65 | MP0005330_cardiomyopathy | 1.31582329 |
| 66 | MP0004036_abnormal_muscle_relaxation | 1.30319331 |
| 67 | MP0001851_eye_inflammation | 1.28203302 |
| 68 | MP0009643_abnormal_urine_homeostasis | 1.28187811 |
| 69 | MP0000015_abnormal_ear_pigmentation | 1.25777644 |
| 70 | MP0002998_abnormal_bone_remodeling | 1.25301449 |
| 71 | MP0004019_abnormal_vitamin_homeostasis | 1.18038871 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 1.17316021 |
| 73 | MP0005666_abnormal_adipose_tissue | 1.16599091 |
| 74 | MP0001873_stomach_inflammation | 1.16491832 |
| 75 | MP0010630_abnormal_cardiac_muscle | 1.16466477 |
| 76 | MP0003448_altered_tumor_morphology | 1.13050505 |
| 77 | MP0005164_abnormal_response_to | 1.11711207 |
| 78 | MP0003828_pulmonary_edema | 1.10480644 |
| 79 | MP0004087_abnormal_muscle_fiber | 1.09674621 |
| 80 | MP0005058_abnormal_lysosome_morphology | 1.08361029 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 1.07950409 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.07698066 |
| 83 | MP0009764_decreased_sensitivity_to | 1.06320452 |
| 84 | MP0006138_congestive_heart_failure | 1.05460305 |
| 85 | MP0001544_abnormal_cardiovascular_syste | 1.05378695 |
| 86 | MP0005385_cardiovascular_system_phenoty | 1.05378695 |
| 87 | MP0003091_abnormal_cell_migration | 1.05341225 |
| 88 | MP0002277_abnormal_respiratory_mucosa | 1.05213925 |
| 89 | MP0003646_muscle_fatigue | 1.05136731 |
| 90 | MP0003868_abnormal_feces_composition | 1.03641816 |
| 91 | MP0004782_abnormal_surfactant_physiolog | 1.03460917 |
| 92 | MP0003724_increased_susceptibility_to | 1.02495038 |
| 93 | MP0005451_abnormal_body_composition | 1.01668640 |
| 94 | MP0001879_abnormal_lymphatic_vessel | 1.00871774 |
| 95 | MP0005670_abnormal_white_adipose | 0.99966291 |
| 96 | MP0002166_altered_tumor_susceptibility | 0.99133483 |
| 97 | MP0002972_abnormal_cardiac_muscle | 0.98942267 |
| 98 | MP0000343_altered_response_to | 0.98510183 |
| 99 | MP0004808_abnormal_hematopoietic_stem | 0.98388983 |
| 100 | MP0004215_abnormal_myocardial_fiber | 0.97639982 |
| 101 | MP0000598_abnormal_liver_morphology | 0.96991433 |
| 102 | MP0000685_abnormal_immune_system | 0.95188064 |
| 103 | MP0008469_abnormal_protein_level | 0.94036135 |
| 104 | MP0000767_abnormal_smooth_muscle | 0.91126214 |
| 105 | MP0001545_abnormal_hematopoietic_system | 0.90398634 |
| 106 | MP0005397_hematopoietic_system_phenotyp | 0.90398634 |
| 107 | MP0000750_abnormal_muscle_regeneration | 0.90132089 |
| 108 | MP0002971_abnormal_brown_adipose | 0.89568048 |
| 109 | MP0003045_fibrosis | 0.88380594 |
| 110 | MP0001835_abnormal_antigen_presentation | 0.86940844 |
| 111 | MP0000249_abnormal_blood_vessel | 0.85661066 |
| 112 | MP0000751_myopathy | 0.85597494 |
| 113 | MP0000371_diluted_coat_color | 0.84956613 |
| 114 | MP0009763_increased_sensitivity_to | 0.84811310 |
| 115 | MP0004947_skin_inflammation | 0.84759668 |
| 116 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84282542 |
| 117 | MP0003690_abnormal_glial_cell | 0.83533068 |
| 118 | MP0001853_heart_inflammation | 0.83178166 |
| 119 | MP0008775_abnormal_heart_ventricle | 0.82930276 |
| 120 | MP0009278_abnormal_bone_marrow | 0.81599262 |
| 121 | MP0001790_abnormal_immune_system | 0.81447181 |
| 122 | MP0005387_immune_system_phenotype | 0.81447181 |
| 123 | MP0008004_abnormal_stomach_pH | 0.80685270 |
| 124 | MP0000604_amyloidosis | 0.79344179 |
| 125 | MP0002419_abnormal_innate_immunity | 0.79259177 |
| 126 | MP0003453_abnormal_keratinocyte_physiol | 0.78921689 |
| 127 | MP0001756_abnormal_urination | 0.78387665 |
| 128 | MP0005166_decreased_susceptibility_to | 0.78041826 |
| 129 | MP0002136_abnormal_kidney_physiology | 0.76281078 |
| 130 | MP0003075_altered_response_to | 0.76078831 |
| 131 | MP0005464_abnormal_platelet_physiology | 0.75837098 |
| 132 | MP0005620_abnormal_muscle_contractility | 0.74348427 |
| 133 | MP0000749_muscle_degeneration | 0.73366470 |
| 134 | MP0005390_skeleton_phenotype | 0.73306036 |
| 135 | MP0001845_abnormal_inflammatory_respons | 0.72791828 |
| 136 | MP0002933_joint_inflammation | 0.72268400 |
| 137 | MP0003279_aneurysm | 0.72172785 |
| 138 | MP0005076_abnormal_cell_differentiation | 0.71944068 |
| 139 | MP0003656_abnormal_erythrocyte_physiolo | 0.71774005 |
| 140 | MP0006054_spinal_hemorrhage | 0.70739366 |
| 141 | MP0004272_abnormal_basement_membrane | 0.70458653 |
| 142 | MP0005334_abnormal_fat_pad | 0.70336980 |
| 143 | MP0002269_muscular_atrophy | 0.70036061 |
| 144 | MP0005165_increased_susceptibility_to | 0.69991571 |
| 145 | MP0005408_hypopigmentation | 0.69703505 |
| 146 | MP0001533_abnormal_skeleton_physiology | 0.68995082 |
| 147 | MP0004484_altered_response_of | 0.68207038 |
| 148 | MP0000569_abnormal_digit_pigmentation | 0.67656987 |
| 149 | MP0005375_adipose_tissue_phenotype | 0.67563780 |
| 150 | MP0005023_abnormal_wound_healing | 0.67425373 |
| 151 | MP0008961_abnormal_basal_metabolism | 0.67375947 |
| 152 | MP0000490_abnormal_crypts_of | 0.67264585 |
| 153 | MP0009785_altered_susceptibility_to | 0.67034376 |
| 154 | MP0001663_abnormal_digestive_system | 0.67020224 |
| 155 | MP0005025_abnormal_response_to | 0.66893734 |
| 156 | MP0001881_abnormal_mammary_gland | 0.66840259 |
| 157 | MP0009642_abnormal_blood_homeostasis | 0.66739447 |
| 158 | MP0004858_abnormal_nervous_system | 0.66245541 |
| 159 | MP0005409_darkened_coat_color | 0.65793015 |
| 160 | MP0003795_abnormal_bone_structure | 0.61509008 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Deep venous thrombosis (HP:0002625) | 5.37553804 |
| 2 | Recurrent bacterial skin infections (HP:0005406) | 5.28014436 |
| 3 | Recurrent abscess formation (HP:0002722) | 5.26507226 |
| 4 | Myositis (HP:0100614) | 4.90657754 |
| 5 | Orchitis (HP:0100796) | 4.73574597 |
| 6 | Intrahepatic cholestasis (HP:0001406) | 4.66662953 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.64179636 |
| 8 | Optic neuritis (HP:0100653) | 4.53288857 |
| 9 | Retrobulbar optic neuritis (HP:0100654) | 4.53288857 |
| 10 | Xanthomatosis (HP:0000991) | 4.31358126 |
| 11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.19862977 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.11586660 |
| 13 | Complement deficiency (HP:0004431) | 4.06085743 |
| 14 | Recurrent fungal infections (HP:0002841) | 3.93962490 |
| 15 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.93196467 |
| 16 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.91742362 |
| 17 | Stomatitis (HP:0010280) | 3.90184257 |
| 18 | T lymphocytopenia (HP:0005403) | 3.88798281 |
| 19 | Hypoglycemic coma (HP:0001325) | 3.83088270 |
| 20 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.76948092 |
| 21 | Abnormality of T cell number (HP:0011839) | 3.72289379 |
| 22 | Mediastinal lymphadenopathy (HP:0100721) | 3.71006240 |
| 23 | Meningitis (HP:0001287) | 3.70698245 |
| 24 | Recurrent skin infections (HP:0001581) | 3.52612629 |
| 25 | Obstructive lung disease (HP:0006536) | 3.45172700 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.45172700 |
| 27 | Right ventricular cardiomyopathy (HP:0011663) | 3.44355473 |
| 28 | Keratoconjunctivitis sicca (HP:0001097) | 3.43097396 |
| 29 | Vasculitis (HP:0002633) | 3.42852256 |
| 30 | Hyperammonemia (HP:0001987) | 3.41666445 |
| 31 | Ketosis (HP:0001946) | 3.40730647 |
| 32 | Hyperlipoproteinemia (HP:0010980) | 3.40570557 |
| 33 | Encephalitis (HP:0002383) | 3.37223217 |
| 34 | Prolonged partial thromboplastin time (HP:0003645) | 3.32558581 |
| 35 | Hypobetalipoproteinemia (HP:0003563) | 3.30267098 |
| 36 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.28795323 |
| 37 | Recurrent cutaneous fungal infections (HP:0011370) | 3.28795323 |
| 38 | Chest pain (HP:0100749) | 3.25507546 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 3.23175812 |
| 40 | Esophageal varix (HP:0002040) | 3.21269776 |
| 41 | Polycythemia (HP:0001901) | 3.18535749 |
| 42 | Gingivitis (HP:0000230) | 3.17470998 |
| 43 | Myocardial infarction (HP:0001658) | 3.16879230 |
| 44 | Hypoalphalipoproteinemia (HP:0003233) | 3.16396316 |
| 45 | Recurrent viral infections (HP:0004429) | 3.14717103 |
| 46 | Urticaria (HP:0001025) | 3.13981342 |
| 47 | Joint hemorrhage (HP:0005261) | 3.10534094 |
| 48 | Keratoconjunctivitis (HP:0001096) | 3.09225064 |
| 49 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.07613712 |
| 50 | Abnormality of complement system (HP:0005339) | 3.06415593 |
| 51 | Ketoacidosis (HP:0001993) | 3.06273107 |
| 52 | Cellulitis (HP:0100658) | 3.06216684 |
| 53 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.05456030 |
| 54 | Arterial thrombosis (HP:0004420) | 3.05082097 |
| 55 | Hyperglycinuria (HP:0003108) | 3.03821810 |
| 56 | Hypolipoproteinemia (HP:0010981) | 3.02548712 |
| 57 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.99371045 |
| 58 | Pulmonary infiltrates (HP:0002113) | 2.94353191 |
| 59 | Epidermoid cyst (HP:0200040) | 2.93968112 |
| 60 | Increased IgE level (HP:0003212) | 2.93667524 |
| 61 | Abnormality of T cells (HP:0002843) | 2.91271075 |
| 62 | Ventricular tachycardia (HP:0004756) | 2.89302153 |
| 63 | Hemoptysis (HP:0002105) | 2.85619291 |
| 64 | Sudden death (HP:0001699) | 2.84878764 |
| 65 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.82230819 |
| 66 | Systemic lupus erythematosus (HP:0002725) | 2.76872255 |
| 67 | Subacute progressive viral hepatitis (HP:0006572) | 2.76717799 |
| 68 | Abnormality of glycine metabolism (HP:0010895) | 2.70972814 |
| 69 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.70972814 |
| 70 | Hyperglycinemia (HP:0002154) | 2.70305731 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.68380042 |
| 72 | Prolonged bleeding time (HP:0003010) | 2.67655026 |
| 73 | Abnormality of the intrinsic pathway (HP:0010989) | 2.67010466 |
| 74 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.66356813 |
| 75 | Myoglobinuria (HP:0002913) | 2.66017298 |
| 76 | Peritonitis (HP:0002586) | 2.65181285 |
| 77 | Leukocytosis (HP:0001974) | 2.64139231 |
| 78 | Pustule (HP:0200039) | 2.63905292 |
| 79 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.62119367 |
| 80 | Fat malabsorption (HP:0002630) | 2.62106001 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.61639187 |
| 82 | Hypercholesterolemia (HP:0003124) | 2.57398833 |
| 83 | Autoimmune hemolytic anemia (HP:0001890) | 2.56137360 |
| 84 | Asymmetric septal hypertrophy (HP:0001670) | 2.54713936 |
| 85 | Osteomyelitis (HP:0002754) | 2.54281601 |
| 86 | Hematochezia (HP:0002573) | 2.52560982 |
| 87 | Viral hepatitis (HP:0006562) | 2.52536455 |
| 88 | Anorexia (HP:0002039) | 2.50406154 |
| 89 | Increased IgM level (HP:0003496) | 2.49815216 |
| 90 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.49485392 |
| 91 | Panhypogammaglobulinemia (HP:0003139) | 2.48770265 |
| 92 | Skin nodule (HP:0200036) | 2.46130726 |
| 93 | Hyporeflexia of lower limbs (HP:0002600) | 2.45378744 |
| 94 | Spontaneous hematomas (HP:0007420) | 2.45060965 |
| 95 | Epistaxis (HP:0000421) | 2.44356156 |
| 96 | Abnormality of purine metabolism (HP:0004352) | 2.41379552 |
| 97 | Colitis (HP:0002583) | 2.41199384 |
| 98 | Granulocytopenia (HP:0001913) | 2.40572624 |
| 99 | Lymphopenia (HP:0001888) | 2.40412568 |
| 100 | Hepatocellular carcinoma (HP:0001402) | 2.36992296 |
| 101 | Exercise-induced muscle cramps (HP:0003710) | 2.36548615 |
| 102 | Gout (HP:0001997) | 2.35366074 |
| 103 | Slow saccadic eye movements (HP:0000514) | 2.34825775 |
| 104 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.34112421 |
| 105 | Abnormality of T cell physiology (HP:0011840) | 2.32166022 |
| 106 | Recurrent bronchitis (HP:0002837) | 2.30718965 |
| 107 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.22446381 |
| 108 | Dicarboxylic aciduria (HP:0003215) | 2.21914747 |
| 109 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.21914747 |
| 110 | Abnormality of the peritoneum (HP:0002585) | 2.21190059 |
| 111 | Gastrointestinal stroma tumor (HP:0100723) | 2.20973818 |
| 112 | Eosinophilia (HP:0001880) | 2.19746379 |
| 113 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.18416084 |
| 114 | Gangrene (HP:0100758) | 2.16527286 |
| 115 | Sepsis (HP:0100806) | 2.15988217 |
| 116 | Interstitial pulmonary disease (HP:0006530) | 2.15628650 |
| 117 | Mitral stenosis (HP:0001718) | 2.15218290 |
| 118 | Hydroxyprolinuria (HP:0003080) | 2.15117192 |
| 119 | Abnormality of proline metabolism (HP:0010907) | 2.15117192 |
| 120 | Episodic fever (HP:0001954) | 2.13646139 |
| 121 | Amyloidosis (HP:0011034) | 2.13471304 |
| 122 | Atrioventricular block (HP:0001678) | 2.12484195 |
| 123 | Hemorrhage of the eye (HP:0011885) | 2.12040645 |
| 124 | Eczematoid dermatitis (HP:0000976) | 2.11785358 |
| 125 | Hypochromic anemia (HP:0001931) | 2.11526675 |
| 126 | Abnormality of nucleobase metabolism (HP:0010932) | 2.11047117 |
| 127 | IgM deficiency (HP:0002850) | 2.10148548 |
| 128 | Agammaglobulinemia (HP:0004432) | 2.10140554 |
| 129 | Metabolic acidosis (HP:0001942) | 2.09931830 |
| 130 | Exercise-induced myalgia (HP:0003738) | 2.09510599 |
| 131 | Glomerulonephritis (HP:0000099) | 2.09345194 |
| 132 | Hyperglycemia (HP:0003074) | 2.09272822 |
| 133 | Hypoglycemic seizures (HP:0002173) | 2.08819646 |
| 134 | Vascular calcification (HP:0004934) | 2.04992295 |
| 135 | Abnormality of the pleura (HP:0002103) | 2.04748856 |
| 136 | Hypergammaglobulinemia (HP:0010702) | 2.03512397 |
| 137 | Rhabdomyolysis (HP:0003201) | 2.03388199 |
| 138 | Muscle fiber splitting (HP:0003555) | 2.02650284 |
| 139 | Nephritis (HP:0000123) | 2.01407960 |
| 140 | Hypochromic microcytic anemia (HP:0004840) | 2.01388075 |
| 141 | Cholelithiasis (HP:0001081) | 2.01158054 |
| 142 | Increased connective tissue (HP:0009025) | 2.01151310 |
| 143 | Lipoatrophy (HP:0100578) | 2.00556357 |
| 144 | Amaurosis fugax (HP:0100576) | 1.99784728 |
| 145 | Skin ulcer (HP:0200042) | 1.99737275 |
| 146 | Lymphangioma (HP:0100764) | 1.98210024 |
| 147 | Palpitations (HP:0001962) | 1.98200144 |
| 148 | Abnormality of the fingertips (HP:0001211) | 1.96694067 |
| 149 | Abnormality of methionine metabolism (HP:0010901) | 1.96078217 |
| 150 | Abnormality of the endocardium (HP:0004306) | 1.95460572 |
| 151 | Late onset (HP:0003584) | 1.95170944 |
| 152 | Verrucae (HP:0200043) | 1.95153166 |
| 153 | Papilloma (HP:0012740) | 1.95153166 |
| 154 | Sensorimotor neuropathy (HP:0007141) | 1.94326593 |
| 155 | Chronic diarrhea (HP:0002028) | 1.94228183 |
| 156 | Abnormality of glycolipid metabolism (HP:0010969) | 1.94115555 |
| 157 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.94115555 |
| 158 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.94115555 |
| 159 | Glomerulopathy (HP:0100820) | 1.92906382 |
| 160 | Hyperbilirubinemia (HP:0002904) | 1.92122786 |
| 161 | Generalized aminoaciduria (HP:0002909) | 1.91845852 |
| 162 | Steatorrhea (HP:0002570) | 1.91429785 |
| 163 | Conjugated hyperbilirubinemia (HP:0002908) | 1.91061661 |
| 164 | Cardiovascular calcification (HP:0011915) | 1.90587464 |
| 165 | Stroke (HP:0001297) | 1.90146482 |
| 166 | Ocular albinism (HP:0001107) | 1.90030595 |
| 167 | Abnormal gallbladder morphology (HP:0012437) | 1.89441137 |
| 168 | Malnutrition (HP:0004395) | 1.89065089 |
| 169 | Aneurysm (HP:0002617) | 1.88501529 |
| 170 | Acute hepatic failure (HP:0006554) | 1.88493242 |
| 171 | Calf muscle hypertrophy (HP:0008981) | 1.88481730 |
| 172 | Autoimmune thrombocytopenia (HP:0001973) | 1.87886138 |
| 173 | Microcytic anemia (HP:0001935) | 1.86797756 |
| 174 | Abnormal cartilage morphology (HP:0002763) | 1.86293722 |
| 175 | Spastic diplegia (HP:0001264) | 1.86174191 |
| 176 | Restrictive lung disease (HP:0002091) | 1.85916601 |
| 177 | Thrombophlebitis (HP:0004418) | 1.85790426 |
| 178 | Pulmonary embolism (HP:0002204) | 1.85415657 |
| 179 | Visceral angiomatosis (HP:0100761) | 1.84751677 |
| 180 | Recurrent pneumonia (HP:0006532) | 1.84749291 |
| 181 | Abnormal platelet volume (HP:0011876) | 1.84269579 |
| 182 | Cerebral hemorrhage (HP:0001342) | 1.83456802 |
| 183 | Abnormality of eosinophils (HP:0001879) | 1.83227899 |
| 184 | Fatigue (HP:0012378) | 1.82540281 |
| 185 | Petechiae (HP:0000967) | 1.82167869 |
| 186 | Axonal loss (HP:0003447) | 1.81130229 |
| 187 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.81078350 |
| 188 | Conjunctival hamartoma (HP:0100780) | 1.79882066 |
| 189 | Loss of speech (HP:0002371) | 1.78886924 |
| 190 | Premature loss of primary teeth (HP:0006323) | 1.78874821 |
| 191 | Syncope (HP:0001279) | 1.76153641 |
| 192 | Heart block (HP:0012722) | 1.75890909 |
| 193 | Gingival bleeding (HP:0000225) | 1.75664040 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.48031789 |
| 2 | TRIB3 | 3.70482268 |
| 3 | ERN1 | 3.40209754 |
| 4 | PKN2 | 3.39948685 |
| 5 | BLK | 3.04156307 |
| 6 | TTN | 3.01429500 |
| 7 | IRAK4 | 2.90410383 |
| 8 | PRPF4B | 2.65087537 |
| 9 | BCKDK | 2.62637194 |
| 10 | FGFR4 | 2.38280306 |
| 11 | TIE1 | 2.36144220 |
| 12 | SIK1 | 2.26881374 |
| 13 | RIPK1 | 2.26115644 |
| 14 | PTK6 | 2.19504373 |
| 15 | EPHB1 | 2.12587559 |
| 16 | TXK | 1.96615297 |
| 17 | TNK2 | 1.96458737 |
| 18 | FES | 1.93536364 |
| 19 | TAOK3 | 1.90859753 |
| 20 | TGFBR2 | 1.87425810 |
| 21 | LATS1 | 1.71441069 |
| 22 | MAP2K3 | 1.70315097 |
| 23 | SMG1 | 1.67145033 |
| 24 | MYLK | 1.64335717 |
| 25 | MAP3K10 | 1.63426712 |
| 26 | TYK2 | 1.60009995 |
| 27 | DMPK | 1.54535603 |
| 28 | FGR | 1.53996881 |
| 29 | LRRK2 | 1.49763331 |
| 30 | SIK3 | 1.48092568 |
| 31 | SYK | 1.47737663 |
| 32 | TBK1 | 1.47134293 |
| 33 | FLT3 | 1.45521891 |
| 34 | MAP3K3 | 1.44627288 |
| 35 | KDR | 1.41629599 |
| 36 | FRK | 1.37190175 |
| 37 | MAP3K14 | 1.34772690 |
| 38 | JAK1 | 1.30440279 |
| 39 | STK10 | 1.29746081 |
| 40 | NEK9 | 1.29539760 |
| 41 | YES1 | 1.24915582 |
| 42 | STK24 | 1.22314330 |
| 43 | LMTK2 | 1.21313856 |
| 44 | LYN | 1.20623073 |
| 45 | CAMK1D | 1.19920000 |
| 46 | MST1R | 1.15715288 |
| 47 | INSRR | 1.15424883 |
| 48 | MAP4K1 | 1.14839156 |
| 49 | TEC | 1.14393218 |
| 50 | EPHA3 | 1.14178482 |
| 51 | MARK3 | 1.12949989 |
| 52 | FGFR3 | 1.10935089 |
| 53 | BMPR2 | 1.09454005 |
| 54 | LCK | 1.08604107 |
| 55 | MAP3K7 | 1.07483444 |
| 56 | CSK | 1.05950189 |
| 57 | PRKAA2 | 1.03854347 |
| 58 | JAK2 | 1.03506136 |
| 59 | IRAK1 | 1.02721345 |
| 60 | STK3 | 1.00325617 |
| 61 | IRAK2 | 0.95454390 |
| 62 | OBSCN | 0.94142876 |
| 63 | PTK2 | 0.91978916 |
| 64 | PDGFRA | 0.91704122 |
| 65 | PIK3CG | 0.87475717 |
| 66 | JAK3 | 0.85407570 |
| 67 | PRKD2 | 0.83021649 |
| 68 | EEF2K | 0.81631931 |
| 69 | CDK12 | 0.79751776 |
| 70 | TAOK2 | 0.77906962 |
| 71 | PIK3CA | 0.77263055 |
| 72 | GRK6 | 0.77119117 |
| 73 | RET | 0.76579167 |
| 74 | CDK6 | 0.76352770 |
| 75 | CHUK | 0.75737354 |
| 76 | ZAP70 | 0.75557500 |
| 77 | CAMK1G | 0.73561317 |
| 78 | MAP3K1 | 0.73148456 |
| 79 | MARK2 | 0.72980316 |
| 80 | MAPK11 | 0.72847223 |
| 81 | KSR2 | 0.70878839 |
| 82 | PDK4 | 0.70567461 |
| 83 | PDK3 | 0.70567461 |
| 84 | MAP3K13 | 0.70239123 |
| 85 | PRKD1 | 0.69105074 |
| 86 | CDC42BPA | 0.67562526 |
| 87 | BMX | 0.66212112 |
| 88 | MATK | 0.63962185 |
| 89 | MAP3K2 | 0.63429536 |
| 90 | MELK | 0.61321714 |
| 91 | MAP2K2 | 0.61254719 |
| 92 | PAK4 | 0.60873774 |
| 93 | TRPM7 | 0.58672111 |
| 94 | MAP3K11 | 0.57843882 |
| 95 | IRAK3 | 0.57813743 |
| 96 | PDPK1 | 0.57299796 |
| 97 | ERBB4 | 0.57026712 |
| 98 | WNK1 | 0.56457365 |
| 99 | BTK | 0.56298673 |
| 100 | GSK3A | 0.56292707 |
| 101 | PRKAA1 | 0.55328229 |
| 102 | FER | 0.54671594 |
| 103 | ITK | 0.54549321 |
| 104 | RAF1 | 0.52405654 |
| 105 | CAMKK2 | 0.52232959 |
| 106 | PDGFRB | 0.51788406 |
| 107 | MAPK12 | 0.51777657 |
| 108 | MET | 0.51535901 |
| 109 | MTOR | 0.51328146 |
| 110 | MAPKAPK3 | 0.51307847 |
| 111 | HIPK2 | 0.51283360 |
| 112 | FYN | 0.50887856 |
| 113 | DAPK2 | 0.50312471 |
| 114 | PIM1 | 0.50118367 |
| 115 | MAP3K6 | 0.49475433 |
| 116 | MAPK7 | 0.49296850 |
| 117 | PDK2 | 0.49188362 |
| 118 | CSF1R | 0.49132583 |
| 119 | KIT | 0.49022842 |
| 120 | IKBKE | 0.48574985 |
| 121 | SGK3 | 0.48178725 |
| 122 | NLK | 0.46745925 |
| 123 | GRK7 | 0.45886894 |
| 124 | EGFR | 0.45798342 |
| 125 | TAOK1 | 0.45359034 |
| 126 | IKBKB | 0.45035614 |
| 127 | PAK3 | 0.44571394 |
| 128 | MAP3K5 | 0.43225528 |
| 129 | EPHA2 | 0.42704602 |
| 130 | CAMKK1 | 0.42650928 |
| 131 | MAPKAPK2 | 0.41704881 |
| 132 | NEK1 | 0.41660812 |
| 133 | AKT3 | 0.41105799 |
| 134 | CDK4 | 0.41053088 |
| 135 | PRKCQ | 0.40452327 |
| 136 | MAP2K1 | 0.40075472 |
| 137 | RPS6KL1 | 0.39818583 |
| 138 | RPS6KC1 | 0.39818583 |
| 139 | TESK2 | 0.39355163 |
| 140 | STK38L | 0.39160660 |
| 141 | MOS | 0.39099817 |
| 142 | PDK1 | 0.39008111 |
| 143 | HCK | 0.38321931 |
| 144 | PTK2B | 0.37728677 |
| 145 | MAP3K8 | 0.37262952 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.85782968 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.44255239 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.07142151 |
| 4 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.91104091 |
| 5 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.83184960 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.71402587 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.46870749 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.46452618 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.41699998 |
| 10 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.39156121 |
| 11 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.39016416 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.27482783 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.26074970 |
| 14 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.26023382 |
| 15 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.20868453 |
| 16 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.13468301 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.08019331 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.05091552 |
| 19 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.02097000 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.99023940 |
| 21 | Tuberculosis_Homo sapiens_hsa05152 | 1.98683613 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.96155202 |
| 23 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.94803071 |
| 24 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.94287541 |
| 25 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.90530293 |
| 26 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.89930858 |
| 27 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.86761062 |
| 28 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.77863154 |
| 29 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.77405277 |
| 30 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.69111067 |
| 31 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.66012930 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.65945082 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65471728 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.64305297 |
| 35 | Malaria_Homo sapiens_hsa05144 | 1.62292284 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.61603156 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.61547076 |
| 38 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.60723166 |
| 39 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.59836835 |
| 40 | Legionellosis_Homo sapiens_hsa05134 | 1.51942474 |
| 41 | Histidine metabolism_Homo sapiens_hsa00340 | 1.51839947 |
| 42 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.50996575 |
| 43 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.50713722 |
| 44 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.49660430 |
| 45 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.47122133 |
| 46 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.43820406 |
| 47 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.43240497 |
| 48 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.42920760 |
| 49 | Bile secretion_Homo sapiens_hsa04976 | 1.42077403 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.38510551 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.35700654 |
| 52 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34320443 |
| 53 | Carbon metabolism_Homo sapiens_hsa01200 | 1.34286081 |
| 54 | Hepatitis B_Homo sapiens_hsa05161 | 1.32878783 |
| 55 | Asthma_Homo sapiens_hsa05310 | 1.32576911 |
| 56 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.29107934 |
| 57 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.27116514 |
| 58 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.25959539 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.23050034 |
| 60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.22838273 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.21504733 |
| 62 | Platelet activation_Homo sapiens_hsa04611 | 1.18327517 |
| 63 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16797074 |
| 64 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.16547539 |
| 65 | Phagosome_Homo sapiens_hsa04145 | 1.09686311 |
| 66 | ABC transporters_Homo sapiens_hsa02010 | 1.09334262 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.09271233 |
| 68 | Retinol metabolism_Homo sapiens_hsa00830 | 1.09246870 |
| 69 | Lysine degradation_Homo sapiens_hsa00310 | 1.08795929 |
| 70 | Apoptosis_Homo sapiens_hsa04210 | 1.06267914 |
| 71 | Insulin resistance_Homo sapiens_hsa04931 | 1.05619553 |
| 72 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01961770 |
| 73 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.01622501 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.99297684 |
| 75 | Endometrial cancer_Homo sapiens_hsa05213 | 0.94684171 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.93536903 |
| 77 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.92458997 |
| 78 | Other glycan degradation_Homo sapiens_hsa00511 | 0.92379564 |
| 79 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.91455254 |
| 80 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89914223 |
| 81 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.88705830 |
| 82 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.87649234 |
| 83 | Prostate cancer_Homo sapiens_hsa05215 | 0.87159425 |
| 84 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.86969795 |
| 85 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.86969424 |
| 86 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.86463630 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.84175075 |
| 88 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.83584254 |
| 89 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.81849282 |
| 90 | Salmonella infection_Homo sapiens_hsa05132 | 0.81444844 |
| 91 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.77453789 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77190804 |
| 93 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.77174063 |
| 94 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.76227271 |
| 95 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.76070687 |
| 96 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.75998408 |
| 97 | HTLV-I infection_Homo sapiens_hsa05166 | 0.75933896 |
| 98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75509041 |
| 99 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.75268958 |
| 100 | Endocytosis_Homo sapiens_hsa04144 | 0.72691314 |
| 101 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.72136316 |
| 102 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.71317895 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.70392185 |
| 104 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.70168547 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.69417711 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.69384553 |
| 107 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.67785013 |
| 108 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.67613232 |
| 109 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.67381459 |
| 110 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.66644841 |
| 111 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66138495 |
| 112 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65975145 |
| 113 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.64707140 |
| 114 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.64348333 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.63565737 |
| 116 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.63270891 |
| 117 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.61297769 |
| 118 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.60744833 |
| 119 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.60042760 |
| 120 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.59984923 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.55305761 |
| 122 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.54878176 |
| 123 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54114114 |
| 124 | Leishmaniasis_Homo sapiens_hsa05140 | 0.53203647 |
| 125 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52640995 |
| 126 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.52391361 |
| 127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.52198680 |
| 128 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.52166376 |
| 129 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.51599512 |
| 130 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.51283621 |
| 131 | Amoebiasis_Homo sapiens_hsa05146 | 0.50856809 |
| 132 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.48906962 |
| 133 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48467702 |
| 134 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.47605174 |
| 135 | Glioma_Homo sapiens_hsa05214 | 0.47197827 |
| 136 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.47010069 |
| 137 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.44159669 |
| 138 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.43703119 |
| 139 | Adherens junction_Homo sapiens_hsa04520 | 0.43350405 |
| 140 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.42871208 |
| 141 | Viral myocarditis_Homo sapiens_hsa05416 | 0.42545425 |
| 142 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41749567 |
| 143 | Galactose metabolism_Homo sapiens_hsa00052 | 0.41428161 |
| 144 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.41414802 |
| 145 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.40163298 |
| 146 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.40127087 |
| 147 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38989132 |
| 148 | Focal adhesion_Homo sapiens_hsa04510 | 0.37962144 |
| 149 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.37281576 |
| 150 | Prion diseases_Homo sapiens_hsa05020 | 0.35439904 |
| 151 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.34872482 |
| 152 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31427976 |
| 153 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.30710194 |
| 154 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.30584443 |
| 155 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.29423178 |
| 156 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.29306859 |
| 157 | Pertussis_Homo sapiens_hsa05133 | 0.29277254 |
| 158 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.29138507 |
| 159 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.28265538 |
| 160 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.28159470 |
| 161 | Bladder cancer_Homo sapiens_hsa05219 | 0.27946145 |
| 162 | Lysosome_Homo sapiens_hsa04142 | 0.27604638 |
| 163 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27354310 |
| 164 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.27110780 |
| 165 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.26653161 |
| 166 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.22796508 |
| 167 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22339794 |
| 168 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.22298958 |
| 169 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.21858080 |
| 170 | Hepatitis C_Homo sapiens_hsa05160 | 0.20267506 |
| 171 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.19972297 |
| 172 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.19711932 |
| 173 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.18551467 |

